XML 13 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Management's Plans for Continuing Operations (Details Textuals) (USD $)
3 Months Ended
Mar. 30, 2013
Management's Plans for Continuing Operations  
Net profit $ 1,468,525
Gain on sale of BluScience 2,891,917
Operating loss exclusive of Gain on Sale of assets to BluScience (1,416,485)
Share based compensation expense 351,590
Operating loss from BluScience 192,399
Additional proceeds expected in 2013 from sale of BluScience 1,333,334
Warrants outstanding 4,389,281
Exercise price $ 0.21
Additional proceeds expected from warrant exercise $ 921,749